Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  138,162 results for ""Angiotensin-converting enzyme inhibitors""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Angiotensin-converting enzyme inhibitors (drug interactions).
Research Starter

Angiotensin-converting enzyme inhibitors (drug interactions).

  • DEFINITION: Medications that block the conversion of a naturally occurring substance, angiotensin, to a more active form....More
  • Salem Press Encyclopedia of Health, 2026. 2p.
Academic Journal

Cardioprotective Effects of Prophylactic Angiotensin-Converting Enzyme Inhibitors in Anthracycline-Induced Cardiotoxicity: A Systematic Review and Meta-analysis of Randomized Trials.

  • Authors : Pizzi D; Department of Medical Biotechnology and Translational Medicine, University of Milan, International Medical School, Milan, Italy.; Fazzini L

Subjects: Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/adverse effects ; Anthracyclines*/Anthracyclines*/Anthracyclines*/adverse effects

  • Source: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2026 May 01; Vol. 87 (5), pp. 348-356. Date of Electronic Publication: 2026 May 01.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7902492 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium-Glucose Cotransporter 2 Inhibitors.

  • Authors : Qian H; Division of Biostatistics and Bioinformatics, University of California, San Diego, Herbert Wertheim School of Public Health and Human Longevity Science, La Jolla, California, USA.; Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey, USA.

Subjects: Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/administration & dosage

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2026 Apr; Vol. 35 (4), pp. e70352.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

×
Academic Journal

Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis.

  • Authors : Ellis AK; Division of Allergy & Immunology, Department of Medicine, Queen's University; Allergy Research Unit, Kingston Health Sciences Centre - Kingston General Hospital Site

Subjects: Anaphylaxis*/Anaphylaxis*/Anaphylaxis*/etiology ; Anaphylaxis*/Anaphylaxis*/Anaphylaxis*/diagnosis ; Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/adverse effects

  • Source: Immunology and allergy clinics of North America [Immunol Allergy Clin North Am] 2026 May; Vol. 46 (2), pp. 291-303. Date of Electronic Publication: 2026 Mar 04.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8805635 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The impacts of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on rates of acute kidney injury in hospitalized adults receiving multiple nephrotoxins.

  • Authors : Tabet M; University of Iowa Hospitals and Clinics-Internal Medicine, 200 Hawkins Drive, Iowa City, IA, 52242, USA.; Vaughan-Sarrazin M

Subjects: Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/epidemiology ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/prevention & control

  • Source: BMC nephrology [BMC Nephrol] 2026 Mar 26; Vol. 27 (1). Date of Electronic Publication: 2026 Mar 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369

Record details

×
Academic Journal

Decreased potential for lymphatic vessel generation is a hallmark of early diagnosed arterial hypertension and can be reversed by treatment with angiotensin converting enzyme inhibitors.

  • Authors : Gliwiński M; Department of Medical Immunology, Medical University of Gdańsk, Gdańsk, Poland.; Koliński T

Subjects: Hypertension*/Hypertension*/Hypertension*/drug therapy ; Hypertension*/Hypertension*/Hypertension*/diagnosis ; Hypertension*/Hypertension*/Hypertension*/immunology

  • Source: Scientific reports [Sci Rep] 2026 Mar 05; Vol. 16 (1). Date of Electronic Publication: 2026 Mar 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of Angiotensin-Converting Enzyme Inhibitors/Angiotensin II Receptor Blockers on Prognosis in Acute Coronary Syndrome Patients with Preserved Ejection Fraction Undergoing Regular Dialysis.

  • Authors : Li Y; Department of Cardiology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100029, China.; Xie E

Subjects: Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/adverse effects ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/drug therapy

  • Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2026 Apr; Vol. 40 (2), pp. 589-598. Date of Electronic Publication: 2025 Jun 10.Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication

Record details

×
  • 1-10 of  138,162 results for ""Angiotensin-converting enzyme inhibitors""